London Co. of Virginia Purchases New Holdings in The Cooper Companies, Inc. $COO

London Co. of Virginia purchased a new stake in The Cooper Companies, Inc. (NASDAQ:COO) in the 4th quarter, HoldingsChannel reports. The fund purchased 2,074,379 shares of the medical device company’s stock, valued at approximately $170,016,000.

Several other hedge funds have also made changes to their positions in COO. JANA Partners Management LP acquired a new position in Cooper Companies in the 3rd quarter valued at approximately $166,917,000. Alecta Tjanstepension Omsesidigt increased its stake in Cooper Companies by 15.8% in the 3rd quarter. Alecta Tjanstepension Omsesidigt now owns 1,563,000 shares of the medical device company’s stock valued at $107,112,000 after buying an additional 213,500 shares during the period. DAVENPORT & Co LLC increased its stake in Cooper Companies by 1,359.7% in the 4th quarter. DAVENPORT & Co LLC now owns 567,203 shares of the medical device company’s stock valued at $46,642,000 after buying an additional 528,346 shares during the period. Swiss Life Asset Management Ltd increased its stake in Cooper Companies by 63.9% in the 3rd quarter. Swiss Life Asset Management Ltd now owns 49,409 shares of the medical device company’s stock valued at $3,387,000 after buying an additional 19,264 shares during the period. Finally, Fluent Financial LLC acquired a new position in Cooper Companies in the 4th quarter valued at approximately $3,517,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Stock Performance

Shares of COO opened at $67.35 on Wednesday. The company’s fifty day moving average is $64.68 and its 200-day moving average is $74.19. The Cooper Companies, Inc. has a 12 month low of $58.89 and a 12 month high of $89.83. The firm has a market cap of $13.14 billion, a price-to-earnings ratio of 57.08, a price-to-earnings-growth ratio of 1.77 and a beta of 0.87. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, topping the consensus estimate of $1.10 by $0.11. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The company had revenue of $1.08 billion for the quarter, compared to analyst estimates of $1.05 billion. During the same quarter in the prior year, the business posted $0.96 EPS. Cooper Companies’s quarterly revenue was up 7.9% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Equities analysts expect that The Cooper Companies, Inc. will post 4.63 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research firms have weighed in on COO. Robert W. Baird dropped their price objective on shares of Cooper Companies from $98.00 to $85.00 and set an “outperform” rating on the stock in a research note on Friday, June 5th. Rothschild & Co Redburn lowered shares of Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 price objective on the stock. in a research note on Wednesday, March 4th. JPMorgan Chase & Co. dropped their price objective on shares of Cooper Companies from $80.00 to $71.00 and set a “neutral” rating on the stock in a research note on Friday, June 5th. Wall Street Zen lowered shares of Cooper Companies from a “buy” rating to a “hold” rating in a research note on Saturday. Finally, Needham & Company LLC dropped their price objective on shares of Cooper Companies from $101.00 to $86.00 and set a “buy” rating on the stock in a research note on Friday, June 5th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have issued a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $81.31.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.